ArticleJACC. Case reports2026
Ventricular Pre-Excitation Pattern in a Competitive Athlete: Not All Pathways Are Created Equal.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVentricular pre-excitation in competitive athletes requires careful evaluation as not all accessory pathways carry equal risk. Fasciculoventricular pathways (FVPs) are a rare, benign subtype that should be distinguished from higher-risk pathways. CASE SUMMARY: A 21-year-old asymptomatic male collegiate cross-country athlete was found to have a ventricular pre-excitation pattern on routine screening electrocardiogram. An electrophysiology study revealed a shortened His-ventricular interval with a fixed pre-excitation pattern during atrial pacing. Intravenous adenosine produced a transient atrioventricular block with a fixed pre-excitation pattern, confirming a benign FVP. No ablation was performed. DISCUSSION: FVPs represent less than 1% of cases of pre-excitation patterns and carry no risk of sudden cardiac death. Ablation is contraindicated (Class III: Harm) because of the risk of complete atrioventricular block. Adenosine testing can noninvasively differentiate FVPs from higher risk pathways. TAKE-HOME MESSAGES: Accurate characterization of accessory pathways is critical. Athletes with FVPs may continue unrestricted sports participation without ablation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.